UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000035661
Receipt No. R000040623
Scientific Title The effect of postoperative analgesia for post operative oxygenation in patients with interstitial pneumonia undergoing surgical biopasy
Date of disclosure of the study information 2019/01/25
Last modified on 2019/11/25 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The effect of postoperative analgesia for post operative oxygenation in patients with interstitial pneumonia undergoing surgical biopasy
Acronym The effect of postoperative analgesia for post operative oxygenation in patients with interstitial pneumonia undergoing surgical biopasy
Scientific Title The effect of postoperative analgesia for post operative oxygenation in patients with interstitial pneumonia undergoing surgical biopasy
Scientific Title:Acronym The effect of postoperative analgesia for post operative oxygenation in patients with interstitial pneumonia undergoing surgical biopasy
Region
Japan

Condition
Condition Inetrstitial Pneumonia
Classification by specialty
Anesthesiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The purpose of this study is investigating the association betweeen postoperative analgesia (epidural anesthesia or intercostal nerve block) and postoperative oxygenation in patients with interstitial pneumonia undergoing surgical biopsy.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Explanatory
Developmental phase Not applicable

Assessment
Primary outcomes The rate of oxygen independent patients in each analgesia group.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification NO
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment Numbered container method

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 Epidural anesthesia with continuous infusion of 0.2% ropivacaine.
Interventions/Control_2 Intra operative sigle shot 0.375% ropivacaine as intercostal nerve block and postoperative continuous intravenous infusion of fentanyl.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Adult patients undergoing surgical lung biopsy for interstitial pneumonia, who admit to ICU after the opration.
Key exclusion criteria Exclusion criteria:1) Patients who have contraindications to epidural anesthesia, 2) Patients underwent home oxygen therapy before the operation, 3) Patients who admit to ICU under tracheal intubation and mechanical ventilation.
Target sample size 70

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Masahiro Gamo
Organization Kanagawa Cardiovascular and Respiratory Center
Division name Department of Anesthesiology
Zip code
Address 6-16-1, Tomiokahigashi, Kanazawa-ku Yokohama-shi, Kanagawa, Japan
TEL 045-701-9581
Email gamou@kanagawa-junko.jp

Public contact
Name of contact person
1st name
Middle name
Last name Natsuhiro Yamamoto
Organization Yokohama City University
Division name Department of Anesthesiology
Zip code
Address 3-9, Fukuura, Kanazawa-ku Yokohama-shi, Kanagawa, Japan
TEL 045-787-2918
Homepage URL
Email natsuyamamo@gmail.com

Sponsor
Institute Kanagawa Cardiovascular and Respiratory Center
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 神奈川県立循環器呼吸器病センター

Other administrative information
Date of disclosure of the study information
2019 Year 01 Month 25 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Terminated
Date of protocol fixation
2019 Year 01 Month 24 Day
Date of IRB
2018 Year 10 Month 15 Day
Anticipated trial start date
2019 Year 01 Month 24 Day
Last follow-up date
2019 Year 11 Month 25 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2019 Year 01 Month 24 Day
Last modified on
2019 Year 11 Month 25 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040623